share_log

What's Next: BioXcel Therapeutics's Earnings Preview

What's Next: BioXcel Therapeutics's Earnings Preview

接下來: bioxcel therapeutics的收益預覽
Benzinga ·  11/13 23:02

BioXcel Therapeutics (NASDAQ:BTAI) is set to give its latest quarterly earnings report on Thursday, 2024-11-14. Here's what investors need to know before the announcement.

BioXcel Therapeutics(納斯達克股票代碼:BTAI)定於2024-11-14星期四發佈其最新的季度收益報告。以下是投資者在宣佈之前需要了解的內容。

Analysts estimate that BioXcel Therapeutics will report an earnings per share (EPS) of $-0.52.

分析師估計,BioXcel Therapeutics將公佈的每股收益(EPS)爲-0.52美元。

The market awaits BioXcel Therapeutics's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.

市場正在等待BioXcel Therapeutics的宣佈,對超出預期併爲下一季度提供樂觀指導的消息寄予厚望。

It's important for new investors to understand that guidance can be a significant driver of stock prices.

對於新投資者來說,重要的是要明白,指引可以成爲股價的重要驅動力。

Overview of Past Earnings

過去的收益概述

During the last quarter, the company reported an EPS beat by $0.50, leading to a 5.06% drop in the share price on the subsequent day.

在上個季度,該公司報告每股收益超過0.50美元,導致第二天股價下跌5.06%。

Here's a look at BioXcel Therapeutics's past performance and the resulting price change:

以下是BioXcel Therapeutics過去的表現以及由此產生的價格變化:

Quarter Q2 2024 Q1 2024 Q4 2023 Q3 2023
EPS Estimate -0.71 -0.70 -0.91 -1.31
EPS Actual -0.21 -0.87 -0.76 -1.58
Price Change % -5.0% -9.0% 4.0% 4.0%
季度 2024 年第二季度 2024 年第一季度 2023 年第四季度 2023 年第三季度
每股收益估算 -0.71 -0.70 -0.91 -1.31
實際每股收益 -0.21 -0.87 -0.76 -1.58
價格變動% -5.0% -9.0% 4.0% 4.0%
bigjpg

Stock Performance

股票表現

Shares of BioXcel Therapeutics were trading at $0.665 as of November 12. Over the last 52-week period, shares are down 84.48%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release.

截至11月12日,BioXcel Therapeutics的股票交易價格爲0.665美元。在過去的52週中,股價下跌了84.48%。鑑於這些回報率通常爲負數,長期股東在發佈本業績時可能會感到沮喪。

To track all earnings releases for BioXcel Therapeutics visit their earnings calendar on our site.

要追蹤BioXcel Therapeutics發佈的所有業績,請訪問我們網站上的業績日曆。

This article was generated by Benzinga's automated content engine and reviewed by an editor.

本文由Benzinga的自動化內容引擎生成,並由編輯審閱。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論